University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipids

Brackenridge, AL, Jackson, N, Jefferson, W, Stolinski, M, Shojaee-Moradie, F, Hovorka, R, Umpleby, AM and Russell-Jones, D (2009) Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipids DIABETIC MEDICINE, 26 (5). 532 - 539. ISSN 0742-3071

[img]
Preview
PDF
Umpleby_Effects of.pdf
Available under License : See the attached licence file.

Download (135Kb)
[img]
Preview
PDF (licence)
SRI_deposit_agreement.pdf

Download (32Kb)
Item Type: Article
Additional Information: The definitive version is available at www.blackwell-synergy.com
Uncontrolled Keywords: Science & Technology, Life Sciences & Biomedicine, Endocrinology & Metabolism, intermediate density lipoprotein, low-density lipoprotein, non-esterified fatty acid, peroxisome proliferators-activated receptor-gamma agonist, Type 2 diabetes, very low-density lipoprotein, IMPROVES GLYCEMIC CONTROL, LOW-DENSITY LIPOPROTEIN, INSULIN-RESISTANCE, APOLIPOPROTEIN-B, CONTROLLED-TRIAL, THERAPY, MELLITUS, DYSLIPIDEMIA, COMBINATION, THIAZOLIDINEDIONES
Related URLs:
Divisions: Faculty of Health and Medical Sciences > Nutrition and Metabolism
Depositing User: Symplectic Elements
Date Deposited: 07 Aug 2012 13:27
Last Modified: 23 Sep 2013 19:32
URI: http://epubs.surrey.ac.uk/id/eprint/711084

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800